120 related articles for article (PubMed ID: 2137141)
1. Treatment of androgenic disorders with dexamethasone: dose-response relationship for suppression of dehydroepiandrosterone sulfate.
Redmond GP; Gidwani GP; Gupta MK; Bedocs NM; Parker R; Skibinski C; Bergfeld W
J Am Acad Dermatol; 1990 Jan; 22(1):91-3. PubMed ID: 2137141
[TBL] [Abstract][Full Text] [Related]
2. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
Carmina E; Lobo RA
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
[TBL] [Abstract][Full Text] [Related]
3. Testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in hyperandrogenic women.
Steinberger E; Smith KD; Rodriguez-Rigau LJ
J Clin Endocrinol Metab; 1984 Sep; 59(3):471-7. PubMed ID: 6235239
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women.
Rittmaster RS; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1985 Sep; 61(3):462-6. PubMed ID: 2991319
[TBL] [Abstract][Full Text] [Related]
5. The endocrine effects of spironolactone used as an antiandrogen.
Young RL; Goldzieher JW; Elkind-Hirsch K
Fertil Steril; 1987 Aug; 48(2):223-8. PubMed ID: 2956130
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of DHEAS in gynecologic endocrinopathy and infertility.
Lobo RA; Paul WL; Goebelsmann U
Obstet Gynecol; 1981 May; 57(5):607-12. PubMed ID: 6261197
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of hirsutism with spironolactone and with spironolactone plus dexamethasone].
Devoto E; Aravena L; Ríos R
Rev Med Chil; 2000 Aug; 128(8):868-75. PubMed ID: 11129548
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
[TBL] [Abstract][Full Text] [Related]
9. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia.
Burke BM; Cunliffe WJ
Br J Dermatol; 1985 Jan; 112(1):124-5. PubMed ID: 3155956
[No Abstract] [Full Text] [Related]
10. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
11. Spironolactone in combination drug therapy for unresponsive hirsutism.
Pittaway DE; Maxson WS; Wentz AC
Fertil Steril; 1985 Jun; 43(6):878-82. PubMed ID: 3158552
[TBL] [Abstract][Full Text] [Related]
12. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
[TBL] [Abstract][Full Text] [Related]
13. Treatment with dexamethasone of androgen excess in adolescent patients.
Emans SJ; Grace E; Woods ER; Mansfield J; Crigler JF
J Pediatr; 1988 May; 112(5):821-6. PubMed ID: 3361397
[TBL] [Abstract][Full Text] [Related]
14. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Lee O; Farquhar C; Toomath R; Jepson R
Cochrane Database Syst Rev; 2000; (2):CD000194. PubMed ID: 10796700
[TBL] [Abstract][Full Text] [Related]
16. Identification of virilizing adrenal tumors in hirsute women.
Derksen J; Nagesser SK; Meinders AE; Haak HR; van de Velde CJ
N Engl J Med; 1994 Oct; 331(15):968-73. PubMed ID: 8084355
[TBL] [Abstract][Full Text] [Related]
17. The effects of spironolactone on adrenal steroidogenesis in hirsute women.
Serafini P; Lobo RA
Fertil Steril; 1985 Nov; 44(5):595-9. PubMed ID: 2996951
[TBL] [Abstract][Full Text] [Related]
18. The addition of dexamethasone to antiandrogen therapy for hirsutism prolongs the duration of remission.
Carmina E; Lobo RA
Fertil Steril; 1998 Jun; 69(6):1075-9. PubMed ID: 9627295
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hirsutism with spironolactone.
Tremblay RR
Clin Endocrinol Metab; 1986 May; 15(2):363-71. PubMed ID: 2941190
[TBL] [Abstract][Full Text] [Related]
20. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
